Dan Ives, an analyst at Wedbush Securities, wrote in investor note Wednesday that the cloud-computing giant "clearly is seeing headwinds in the field and thus is trying to quickly adjust to a softening demand environment."

Source: https://abc7.com/salesforce-job-cuts-layoffs-employee-headcount-count/12651464/

Dan Ives of Wedbush raises the price target for Microsoft to $425, citing advancements in AI and new custom computing chips.

Source: https://www.benzinga.com/trading-ideas/long-ideas/23/11/35856445/benzinga-bulls-and-bears-tesla-microsoft-bitcoin-and-why-dogecoin-appears-on-verge-of-ma

Dan Ives, tech analyst at Wedbush, said: ‘Apple delivered solid results with services the shining star while iPhone revenues met expectations.

Source: https://www.dailymail.co.uk/money/markets/article-12706041/Apple-revenues-slide-despite-record-iPhone-sales.html?ns_mchannel=rss&ns_campaign=1490&ito=1490

Day One Biopharmaceuticals ( had its price objective reduced by Wedbush from $39.00 to $35.00 in a note issued to investors on Tuesday, reports.

Source: https://www.etfdailynews.com/2023/11/07/day-one-biopharmaceuticals-nasdaqdawn-price-target-cut-to-35-00/

Finally, Wedbush lifted their target price on shares of Chipotle Mexican Grill from $1,800.00 to $2,080.00 and gave the company an “outperform” rating in a research report on Wednesday, February 8th.

Source: https://www.americanbankingnews.com/2023/03/06/belpointe-asset-management-llc-trims-stock-position-in-chipotle-mexican-grill-inc-nysecmg.html

Finally, Wedbush raised their target price on shares of Amazon.com from $125.00 to $129.00 in a research report on Friday, April 28th.

Source: https://www.etfdailynews.com/2023/05/26/l-m-kohn-company-decreases-stock-position-in-amazon-com-inc-nasdaqamzn/

Finally, Wedbush reaffirmed a “neutral” rating and issued a $140.00 target price on shares of International Business Machines in a report on Thursday, July 20th.

Source: https://www.etfdailynews.com/2023/09/02/hrt-financial-lp-buys-new-shares-in-international-business-machines-co-nyseibm/

Finally, Wedbush reiterated an “outperform” rating on shares of Evolent Health in a research report on Thursday, November 16th.

Source: https://www.dailypolitical.com/2023/12/04/hsbc-holdings-plc-invests-2-67-million-in-evolent-health-inc-nyseevh.html

Finally, Wedbush Securities Inc. purchased a new stake in Enphase Energy in the 1st quarter worth about $434,000.

Source: https://www.dailypolitical.com/2023/08/16/enphase-energy-inc-nasdaqenph-short-interest-up-7-7-in-july.html

Finally, Wedbush Securities Inc. raised its position in Triton International by 4.4% during the 3rd quarter.

Source: https://www.etfdailynews.com/2023/01/19/comerica-bank-sells-27884-shares-of-triton-international-limited-nysetrtn/

One investment firm known for years as a Netflix bear, Wedbush Securities, has become a bull.

Source: https://deadline.com/2023/01/netflix-q4-earnings-streaming-wall-street-1235226002/

Tesla Poised to Benefit From Musk Stepping Down as Twitter Chief Executive, Wedbush Say.

Source: https://www.marketscreener.com/quote/stock/META-PLATFORMS-INC-10547141/news/FACEBOOK-YOUTUBE-TWITTER-DOWN-AGAIN-IN-PAKISTAN-AFTER-HAVING-B-8230-43837688/?utm_medium=RSS&utm_content=20230513

Wedbush also issued estimates for Brinker International’s FY2025 earnings at $3.81 EPS.

Source: https://www.etfdailynews.com/2023/08/19/brinker-international-nyseeat-receives-neutral-rating-from-wedbush/

Wedbush began coverage on shares of Okta in a report on Wednesday, December 14th.

Source: https://www.etfdailynews.com/2023/01/16/comerica-bank-makes-new-investment-in-okta-inc-nasdaqokta/

Wedbush boosted their target price on shares of Apple from $230.00 to $240.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 13th.

Source: https://www.americanbankingnews.com/2023/09/23/capital-investment-advisors-llc-sells-49856-shares-of-apple-inc-nasdaqaapl.html

Wedbush currently has a “Outperform” rating and a $95.00 target price on the stock.

Source: https://www.americanbankingnews.com/2023/08/01/brokers-set-expectations-for-pennymac-financial-services-inc-s-q1-2024-earnings-nysepfsi-3.html

Wedbush cut D.R. Horton from an “outperform” rating to a “neutral” rating and cut their price target for the stock from $104.00 to $96.00 in a report on Wednesday, January 25th.

Source: https://www.americanbankingnews.com/2023/02/24/brown-advisory-inc-has-431000-stake-in-d-r-horton-inc-nysedhi-2.html

Wedbush cut shares of Design Therapeutics from an outperform rating to a neutral rating and reduced their target price for the stock from $19.00 to $6.00 in a report on Tuesday, August 15th.

Source: https://www.etfdailynews.com/2023/11/18/design-therapeutics-nasdaqdsgn-cut-to-neutral-at-piper-sandler/

Wedbush cut their price objective on First Foundation from $10.00 to $8.00 in a report on Friday, April 28th.

Source: https://www.dailypolitical.com/2023/07/01/da-davidson-comments-on-first-foundation-inc-s-fy2023-earnings-nasdaqffwm.html

Wedbush cut their price target on shares of Jack in the Box from $95.00 to $72.00 and set a neutral rating on the stock in a research note on Friday, November 17th.

Source: https://www.etfdailynews.com/2023/11/26/jack-in-the-box-nasdaqjack-price-target-lowered-to-78-00-at-morgan-stanley/